Olympus medical systems corp.(omsc) received a literature titled "real-life indications and outcome of electrocautery-enhanced lumen-apposing metal stents in a tertiary center".Literature summary purpose: electrocautery-enhanced lumen-apposing stents (ec-lams) were originally designed for the drainage of the gallbladder, bile duct, and pancreas pseudocysts.Throughout the years, several off-label indications were established.This study aims to evaluate the indication, safety, efficacy, and outcome of all lams implanted in a single tertiary referral center.Methods: from (b)(6) 2016 to (b)(6) 2022, all patients undergoing lams placement in a single tertiary center were included.We present a detailed analysis of indications, success rates, and complications based on a retrospective analysis of our prospectively maintained database.Results: a total of (b)(4) between (b)(6) 2016 and (b)(6)l 2022.Indications were walled-off pancreatic necrosis (b)(4), bile duct obstructions (b)(4), acute cholecystitis (b)(4), pancreas pseudocysts (b)(4), postoperative collections (b)(4), postoperative pancreatic fistulas (b)(4), and gastro-gastrostomy/jejunostomy (b)(4) to enable to perform an endoscopic retrograde cholangiopancreatography in patients with gastric bypass.Technical success was (b)(4)).A total of (b)(4) adverse events were observed.In (b)(4)), severe complications occurred, which required acute surgery; one displacement was closed through clips.In (b)(4) bleedings occurred during necrosectomy or from mucosal erosions at the stent side, respectively, that were treated with endoclips.Conclusions: (electrocautery-enhanced lumen-apposing stents (ec-lamss) are safe and show a high technical success rate in all indications.In everyday clinical practice, the main indications are hepato-pancreato-biliary, and therefore an hepato-pan-creato-biliary-surgical department should have ec-lams in their armamentarium.Type of adverse events/number of patients event1: bleeding during necrosectomy (1) event2: bleeding after implantation of the stent (1) event3: bleeding by mucosal erosion from the stent (5) event4: perforation (2) event5: dislocation (1) event6: acute cholecistitis (1) event7: acute abdomen (1) event8: deaths (2).Per literature the 2 patients deaths within the first month after stent placement were unrelated to the procedure.This literature article requires 6 reports.The related patient identifiers are as follows: 1) patient identifier # (b)(6), single use retrieval basket fg-v422pr, sn-unk 2) patient identifier # (b)(6), single use retrieval basket, fg-v422pr, sn-unk 3) patient identifier # (b)(6), evis exera ii ultrasound gastrovideoscope, gf-uct180, sn-unk (this report) 4) patient identifier # (b)(6), evis exera ii ultrasound gastrovideoscope, gf-uct180, sn-unk 5) patient identifier # (b)(6), ultrasonic gastrovideoscope, gf-uct140-al5, sn-unk 6) patient identifier # (b)(6), ultrasonic gastrovideoscope, gf-uct140-al5, sn-unk.There is no report of any olympus device malfunction in any procedure described in this study.
|